Sakar Healthcare Stock Surges on EU Approval

  Published 11 months ago

Sakar Healthcare shares rise 5% after EU approval for cancer drug, with more product approvals expected soon.

  • India’s Sakar Healthcare gains 5% as EU approves colorectal cancer injection.
  • The company expects EU approvals for oral solids and injections in the next months.
  • Trading volume triples to 115k shares; stock up 16% year to date.

You might like these

Jupiter Wagons CFO Steps Down

Reliance Industries: JPMorgan Upgrades Outlook

Indian Oil Pushes SAF, Green Hydrogen

Hero MotoCorp Cuts Prices with GST 2.0

Gold Dips Amid Profit-Taking, Geopolitical Tensions & Fed Watch

India Bond Yields Steady, Rate Cut Expected

Confidence Petroleum Expands Auto LPG Network

News that matters the most ⚡